Picture of Mesa Laboratories logo

MLAB — Mesa Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Mesa Laboratories Inc reports results for the quarter ended June 30 - Earnings Summary

Mesa Laboratories Inc MLAB.OQ reported quarterly adjusted earnings of 85 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 84 cents.  The mean expectation of three analysts for the quarter was for earnings of 44 cents per share. Wall Street expected results to range from 7 cents to 87 cents per share.

Revenue rose 2.4% to $59.54 million from a year ago; analysts expected $60.58 million.

Mesa Laboratories Inc's reported EPS for the quarter was 85 cents​.

The company reported quarterly net income of $4.72 million.

Mesa Laboratories Inc shares had fallen by 18.8% this quarter and lost 42.0% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 60.5% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is  "buy."

Wall Street's median 12-month price target for Mesa Laboratories Inc is $120.00, about 36.3% above its last closing price of $76.50

This summary was machine generated from LSEG data August 5 at 02:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
Jun. 30 20250.440.85Beat
Mar. 31 20251.09-1.31Missed
Dec. 31 20241.75-0.26Missed
Sep. 30 20241.380.80Missed

Recent news on Mesa Laboratories

See all news